ArticleCardiovascular diabetology2017
Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry.
Article in Cardiovascular diabetology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care.Cardiovascular diabetology · 2019Trial
- Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics.Diabetes/metabolism research and reviews · 2026Review
- Correlations between multiple obesity diagnostic criteria and fracture risk as well as cardiovascular diseases in patients with diabetes mellitus.Frontiers in cardiovascular medicine · 2026Article
- Cardiovascular disease among bariatric surgery candidates: coronary artery screening and the impact of metabolic syndrome.Diabetology & metabolic syndrome · 2024Article
- 'Super Rehab': can we achieve coronary artery disease regression? A feasibility study protocol.BMJ open · 2023Article
- Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes.Biomedicines · 2023Review
- Comparison of Framingham Cardiovascular Risk Criteria and ASCVD Score in Iranian Obese Patients.Iranian journal of public health · 2023Article
- Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain.Diabetes care · 2021Article
- Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review.Frontiers in pharmacology · 2021Review
- Angiopoietin-Like Proteins 2 and 3 in Children and Adolescents with Obesity and Their Relationship with Hypertension and Metabolic Syndrome.International journal of hypertension · 2021Article
- Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: aCardiovascular diabetology · 2020Article
- Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia.Heart (British Cardiac Society) · 2020Article
- The aging human body shape.NPJ aging and mechanisms of disease · 2020Article
- Serial coronary computed tomography angiography-verified coronary plaque progression: comparison of stented patients with or without diabetes.Cardiovascular diabetology · 2019Article
- Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study.Cardiovascular diabetology · 2019Observational
- Obesity and metabolic syndrome in COPD: Is exercise the answer?Chronic respiratory disease · 2018Review
- The role of obesity in carotid plaque instability: interaction with age, gender, and cardiovascular risk factors.Cardiovascular diabetology · 2018Article
- Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study.Cardiovascular diabetology · 2018Article
- Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.Cardiovascular diabetology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
objectiveTo investigate the relationship among body mass index (BMI), cardiometabolic risk and coronary artery disease (CAD) among patients undergoing coronary computed tomography angiography (CTA).
methodsRetrospective cohort study of 1118 patients, who underwent coronary CTA at two centers from September 2004 to October 2011. Coronary CTA were categorized as normal, nonobstructive CAD (<50%), or obstructive CAD (≥50%) in addition to segment involvement (SIS) and stenosis scores. Extensive CAD was defined as SIS > 4. Association of BMI with cardiovascular prognosis was evaluated using multivariable fractional polynomial models.
resultsMean age of the cohort was 57 ± 13 years with median follow-up of 3.2 years. Increasing BMI was associated with MetS (OR 1.28 per 1 kg/m
conclusionsCompared to normal BMI, there was an increased burden of CAD for BMI > 25 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.